AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Propofol in Nigeria
6 products registered with NAFDAC — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Propofol Injection BP 10 mg/mL $ Injection | A4-101748 | JOVIEX HEALTHCARE LTD | active | 25 Nov 2030 |
| Propofol Injection 10 mg/mL** Emulsion for injection/infusion | A4-101673 | T.P Drugs Limited | active | 28 Oct 2030 |
| Annvan Propofol Injection 10 mg** Emulsion for injection/infusion | A4-101614 | Annie Pharma Limited | active | 28 Oct 2030 |
| Diprivan 1% Injection** Emulsion for injection/infusion | A4-6962 | AstraZeneca Nigeria Limited | active | 21 Oct 2027 |
| Troypofol Emulsion for injection/infusion | B4-4341 | Sewell Pharmaceuticals Limited | active | 27 Oct 2026 |
| Propofol Injection Emulsion for injection | C4-1840 | Zadip Healthcare Ltd | active | 27 Sept 2026 |
Propofol — NAFDAC Registration Details
NAFDAC (Nigeria) has 6 registered products containing Propofol, of which 6 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Propofol registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.